World's Best Scientists 2026 revealed!
VIEW LIST
Matteo S. Carlino

Matteo S. Carlino

University of Sydney
Australia

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 83 15332 14417 511 498 580 59979

Matteo S. Carlino publications per year

The chart shows the history of publications by Matteo S. Carlino between 1985 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Matteo S. Carlino published across 42 years, from 1985 to 2026, averaging 15.7 papers a year. Output peaked at 202 publications in 2023. 50 of the 659 publications appeared in the last two years.

No. of publications
50 100 150 200
Bar chart. Horizontal axis: year, 1985 to 2026. Vertical axis: number of publications, 0 to 202. Peak 202 publications in 2023. 1985: 1 publication 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 0 publications 1999: 0 publications 2000: 0 publications 2001: 0 publications 2002: 0 publications 2003: 0 publications 2004: 0 publications 2005: 0 publications 2006: 0 publications 2007: 0 publications 2008: 0 publications 2009: 1 publication 2010: 1 publication 2011: 2 publications 2012: 2 publications 2013: 3 publications 2014: 9 publications 2015: 32 publications 2016: 29 publications 2017: 38 publications 2018: 35 publications 2019: 51 publications 2020: 50 publications 2021: 66 publications 2022: 40 publications 2023: 202 publications 2024: 47 publications 2025: 49 publications 2026: 1 publication
1985 2026

659 publications in total across all disciplines

View publications per year as a table
Matteo S. Carlino: publications per year, 1985 to 2026
Year Publications
1985 1
1986 0
1987 0
1988 0
1989 0
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 0
1997 0
1998 0
1999 0
2000 0
2001 0
2002 0
2003 0
2004 0
2005 0
2006 0
2007 0
2008 0
2009 1
2010 1
2011 2
2012 2
2013 3
2014 9
2015 32
2016 29
2017 38
2018 35
2019 51
2020 50
2021 66
2022 40
2023 202
2024 47
2025 49
2026 1
Total 659
Download as CSV

Matteo S. Carlino publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Matteo S. Carlino sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 561–580 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 580 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504 580
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Matteo S. Carlino D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Matteo S. Carlino sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 82–83 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027 83
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Matteo S. Carlino is affiliated with the University of Sydney in Australia. Their research predominantly focuses on medicine with significant contributions to oncology and molecular biology subfields. The scientist's work extensively covers cancer immunotherapy, particularly related to melanoma.

The main areas of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of research involve:

  • Oncology
  • Molecular Biology
  • Immunology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Matteo S. Carlino's primary topics of investigation span:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Cutaneous Melanoma Detection and Management
  • Melanoma and MAPK Pathways
  • Immunotherapy and Immune Responses
  • Cancer Genomics and Diagnostics
  • Brain Metastases and Treatment

Frequent collaborators include:

  • Georgina V. Long
  • Alexander M. Menzies
  • Richard A. Scolyer
  • Serigne Lo
  • Paolo A. Ascierto

Key journals and venues where Matteo S. Carlino publishes work include:

  • Journal of Clinical Oncology
  • European Journal of Cancer
  • Annals of Oncology
  • Journal for ImmunoTherapy of Cancer
  • Cancer Research

Recent papers authored or co-authored by Matteo S. Carlino are:

  • Immune checkpoint inhibitors in melanoma, 2021, The Lancet
  • Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma, 2022, Zurich Open Repository and Archive (University of Zurich)
  • Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study, 2024, The Lancet
  • Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo, 2020, JAMA Oncology
  • Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial, 2021, The Lancet Oncology

Best Publications

  • Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

    James Larkin;Vanna Chiarion-Sileni;Rene Gonzalez;Jean Jacques Grob

  • Pembrolizumab versus Ipilimumab in Advanced Melanoma

    Caroline Robert;Caroline Robert;Caroline Robert;Jacob Schachter;Georgina V. Long;Ana Arance

  • Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

    Jedd D. Wolchok;Vanna Chiarion-Sileni;Rene Gonzalez;Piotr Rutkowski

  • Five-year survival with combined nivolumab and ipilimumab in advanced melanoma: New England Journal of Medicine

    J. Larkin;V. Chiarion-Sileni;R. Gonzalez;J.-J. Grob

  • Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

    Daniel Y. Wang;Joe Elie Salem;Joe Elie Salem;Justine V. Cohen;Sunandana Chandra

  • Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

    Alexander M.M. Eggermont;Christian U. Blank;Mario Mandala;Georgina V. Long

  • Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

    Antoni Ribas;Igor Puzanov;Reinhard Dummer;Dirk Schadendorf

  • Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

    Jacob Schachter;Antoni Ribas;Georgina V. Long;Ana Arance

  • Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

    Jarushka Naidoo;Xuan Wang;Xuan Wang;Xuan Wang;Kaitlin M. Woo;Kaitlin M. Woo;Tunc Iyriboz;Tunc Iyriboz

  • Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

    Georgina V Long;Reinhard Dummer;Omid Hamid;Thomas F Gajewski

  • Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

    Caroline Robert;Antoni Ribas;Jacob Schachter;Ana Arance

  • Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

    Alexander M. Menzies;Alexander M. Menzies;D. B. Johnson;S. Ramanujam;V. G. Atkinson

  • Immune checkpoint inhibitors in melanoma

    Matteo S Carlino;James Larkin;Georgina V Long

  • Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

    Tuba N. Gide;Camelia Quek;Alexander M. Menzies;Annie T. Tasker

  • Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders

    Douglas B. Johnson;Ryan J. Sullivan;Patrick A. Ott;Matteo S. Carlino

  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

    Jennifer L. McQuade;Carrie R. Daniel;Kenneth R. Hess;Carmen Mak

  • BRAF inhibitor resistance mechanisms in metastatic melanoma; spectrum and clinical impact.

    Helen Rizos;Alexander M. Menzies;Gulietta M. Pupo;Matteo S. Carlino

  • Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma

    Alexander M. Menzies;Lauren E. Haydu;Lydia Visintin;Lydia Visintin;Lydia Visintin;Matteo S. Carlino;Matteo S. Carlino

  • Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

    Jedd D. Wolchok;Vanna Chiarion-Sileni;Rene Gonzalez;Jean-Jacques Grob

  • Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

    Alexander M.M. Eggermont;Michal Kicinski;Christian U. Blank;Mario Mandala

Frequent Co-Authors

Georgina V. Long
Georgina V. Long University of Sydney
Alexander M. Menzies
Alexander M. Menzies University of Sydney
Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Richard F. Kefford
Richard F. Kefford Macquarie University
Helen Rizos
Helen Rizos Macquarie University
Caroline Robert
Caroline Robert University of Paris-Saclay
James Larkin
James Larkin Royal Marsden NHS Foundation Trust
Antoni Ribas
Antoni Ribas University of California, Los Angeles
John F. Thompson
John F. Thompson University of Sydney
Douglas B. Johnson
Douglas B. Johnson Vanderbilt University Medical Center

External Links

Personal website of Matteo S. Carlino

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but eager to explore alternative or complementary career pathways, there are several online degree options available. Healthcare administration is a rapidly growing field, and students can fast-track their leadership journey with healthcare administration degree programs offered fully online.

Nursing professionals can advance their clinical expertise through asn to fnp programs, allowing registered nurses to become Family Nurse Practitioners with greater autonomy and responsibility.

For those drawn to wellness, nutrition, and preventive care, earning an online bs in nutrition can open doors to careers in dietetics, health education, or allied health sectors.

It’s crucial to choose accredited programs for quality assurance and better career prospects. Interested in administration roles? Explore which online healthcare administration programs have cahme accreditation? to ensure your degree meets recognized healthcare standards.

Best Scientists Citing Matteo S. Carlino

Georgina V. Long

Georgina V. Long

University of Sydney

Publications: 212

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 160

Paolo A. Ascierto

Paolo A. Ascierto

National Institutes of Health

Publications: 149

Richard A. Scolyer

Richard A. Scolyer

Royal Prince Alfred Hospital

Publications: 147

Caroline Robert

Caroline Robert

University of Paris-Saclay

Publications: 133

Douglas B. Johnson

Douglas B. Johnson

Vanderbilt University Medical Center

Publications: 128

Michael A. Postow

Michael A. Postow

Memorial Sloan Kettering Cancer Center

Publications: 122

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 110

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 108

F. Stephen Hodi

F. Stephen Hodi

Harvard University

Publications: 107

Ryan J. Sullivan

Ryan J. Sullivan

Harvard University

Publications: 102

Alexander M. Menzies

Alexander M. Menzies

University of Sydney

Publications: 99

Keith T. Flaherty

Keith T. Flaherty

Harvard University

Publications: 99

Claus Garbe

Claus Garbe

University of Tübingen

Publications: 95

Grant A. McArthur

Grant A. McArthur

Peter MacCallum Cancer Centre

Publications: 93

John F. Thompson

John F. Thompson

University of Sydney

Publications: 93

Trending Scientists

Jacoba M. Spikman

Jacoba M. Spikman

University of Groningen

Daniel Huber

Daniel Huber

University of Hawaii at Manoa

Joshua T. Ackerman

Joshua T. Ackerman

United States Geological Survey

Maria Chiara Monti

Maria Chiara Monti

University of Salerno

Christoph H. Borchers

Christoph H. Borchers

McGill University

Luke W. Guddat

Luke W. Guddat

University of Queensland

Andre Bernards

Andre Bernards

Harvard University

Fred D. Ledley

Fred D. Ledley

Bentley University

Roberto P. Garofalo

Roberto P. Garofalo

The University of Texas Medical Branch at Galveston

Dejan Milojicic

Dejan Milojicic

Hewlett-Packard (United States)

Hamid Pirahesh

Hamid Pirahesh

IBM (United States)

Mandayam A. Srinivasan

Mandayam A. Srinivasan

University College London

Kit H. Bowen

Kit H. Bowen

Johns Hopkins University

Stephen Naylor

Stephen Naylor

Mayo Clinic

Pierre Gressens

Pierre Gressens

Université Paris Cité

Jack Goldberg

Jack Goldberg

University of Washington

Related Medicine Rankings & Guides

2027 Best Online Associate Science in Nursing (ASN) Programs

2027 Best Online Associate Science in Nursing (ASN) Programs
2027 Most Affordable Healthcare Administration Degrees Online

2027 Most Affordable Healthcare Administration Degrees Online
2027 Medical Lab Tech Programs Online: Best Schools

2027 Medical Lab Tech Programs Online: Best Schools
2027 Fastest Online Master's Degree in Healthcare Management Programs

2027 Fastest Online Master's Degree in Healthcare Management Programs
2027 Best Online Nursing Degree Programs for Non-Nurses

2027 Best Online Nursing Degree Programs for Non-Nurses
2027 Fastest Online MSN in Psychiatric Mental Health NP Programs

2027 Fastest Online MSN in Psychiatric Mental Health NP Programs
September 2027 Best Online Certificate Programs in Medical Billing & Coding Programs

September 2027 Best Online Certificate Programs in Medical Billing & Coding Programs
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs
2027 Best Online Surgical Tech Certificate Programs

2027 Best Online Surgical Tech Certificate Programs
2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs
2027 Most Affordable Online Master's Degrees in Nutrition

2027 Most Affordable Online Master's Degrees in Nutrition
2027 Best Online Nurse Practitioner Degree Programs

2027 Best Online Nurse Practitioner Degree Programs
2027 Best Online Master’s in Clinical Research Programs

2027 Best Online Master’s in Clinical Research Programs
2027 Easiest RN-to-MSN Online Programs to Get Into

2027 Easiest RN-to-MSN Online Programs to Get Into
2027 Cheapest Online Nursing Informatics Degree Programs

2027 Cheapest Online Nursing Informatics Degree Programs
2027 Best Online Associate in Physical Therapy Assistant Programs

2027 Best Online Associate in Physical Therapy Assistant Programs
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs
2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus
2027 Most Affordable Online Health Information Management Degree Programs

2027 Most Affordable Online Health Information Management Degree Programs
2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus
2027 Fastest Online BSN to MSN Bridge Programs

2027 Fastest Online BSN to MSN Bridge Programs

Recently Published Articles

2027 Agriculture Degree Programs With No GRE or GMAT Requirements

2027 Agriculture Degree Programs With No GRE or GMAT Requirements
2027 GPA, Test Scores, and Experience Needed for Surgical Tech Degree Programs

2027 GPA, Test Scores, and Experience Needed for Surgical Tech Degree Programs
2027 Military-Friendly Online Science Bachelor's Degree Programs

2027 Military-Friendly Online Science Bachelor's Degree Programs
2027 How to Become a Mental Health Counselor in Connecticut

2027 How to Become a Mental Health Counselor in Connecticut
2027 Best Online DNP Nursing Informatics Programs

2027 Best Online DNP Nursing Informatics Programs
2027 How to Become a High School History Teacher in New Mexico: Requirements & Certification

2027 How to Become a High School History Teacher in New Mexico: Requirements & Certification
2027 Which Health Informatics Degree Careers Offer the Best Return Without Graduate School?

2027 Which Health Informatics Degree Careers Offer the Best Return Without Graduate School?
2027 How to Become a School Psychologist in Arkansas - School Psychology Programs and Certifications Online & Campus

2027 How to Become a School Psychologist in Arkansas - School Psychology Programs and Certifications Online & Campus
2027 Best PsyD Programs in Wisconsin: APA Accredited Online & Campus

2027 Best PsyD Programs in Wisconsin: APA Accredited Online & Campus
2027 How to Become a Licensed Therapist (LPC) in Los Angeles, CA

2027 How to Become a Licensed Therapist (LPC) in Los Angeles, CA
2027 Admission Requirements for Sports Management Degree Programs

2027 Admission Requirements for Sports Management Degree Programs
2027 Is Grand Canyon University's Online MEd in Secondary Education: STEM Worth It? What Students Should Know

2027 Is Grand Canyon University's Online MEd in Secondary Education: STEM Worth It? What Students Should Know
2027 Theology Degree Completion Programs for Working Adults

2027 Theology Degree Completion Programs for Working Adults
2027 Industry Demand for Computer Science Master's Graduates: Job Outlook & Hiring Trends

2027 Industry Demand for Computer Science Master's Graduates: Job Outlook & Hiring Trends
2027 Is Forensic Science a Good Career: Benefits, Job Market & Career Growth

2027 Is Forensic Science a Good Career: Benefits, Job Market & Career Growth
2027 Biotechnology Degree Levels Explained: Bachelor's vs Master's vs Doctorate

2027 Biotechnology Degree Levels Explained: Bachelor's vs Master's vs Doctorate
2027 Medical Illustrator Careers: Skills, Education, Salary & Job Outlook

2027 Medical Illustrator Careers: Skills, Education, Salary & Job Outlook
2027 Easiest Online Interdisciplinary Studies Bachelor's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions

2027 Easiest Online Interdisciplinary Studies Bachelor's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions
2027 Last-Minute Admission AI Master's Programs Still Accepting Students

2027 Last-Minute Admission AI Master's Programs Still Accepting Students
2027 Fastest Online Animation Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Animation Degree Programs You Can Finish in Under 2 Years
2027 Online General Management Doctorate Programs for Licensed Professionals

2027 Online General Management Doctorate Programs for Licensed Professionals